January 03, 2013
Wyeth Inc. has agreed to pay $2 million to resolve class action claims alleging the pharmaceutical company breached its fiduciary duty by directing employees to invest in stock that Wyeth should have known was improperly inflated, according to court documents filed Thursday in New York.